Relatively high prevalence of drug resistance among antiretroviral-naive patients from henan, central China

AIDS Research and Human Retroviruses

Volumn 30, Issue 2, 2014, Pages 160-164

  Li, Lingnuo ^a   Sun, Binlian ^a   Zeng, Haiyan ^a   Sun, Zhiwu ^a   Sun, Guoqing ^b   Yang, Rongge ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b Center for Disease Control and Prevention of Henan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ENVELOPE PROTEIN; GAG PROTEIN; INTEGRASE; INTEGRASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOTIDE; POL PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CHILD; CHINA; FEMALE; GENE MUTATION; GENETIC SIMILARITY; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UNINDEXED SEQUENCE; VIRUS GENE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84893483440     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0144     Document Type: Article

References (18)

1. Estimates for the HIV/AIDS Epidemic in China. P.R. China, 2011.
2. Liu J, Chen X, Xie Q, et al.: Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. AIDS Res Hum Retroviruses 2011;27(8):925-930.
3. Wittkop L, Gunthard HF, de Wolf F, et al.: Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): A European multicohort study. Lancet Infect Dis 2011;11(5):363-371.
4. Wu Z, Liu Z, and Detels R: HIV-1 infection in commercial plasma donors in China. Lancet 1995;346(8966):61-62.
5. Blood Products Regulation Act. P.R. China, December 30, 1996.
6. Ji G, Detels R, Wu Z, and Yin Y: Correlates of HIV infection among former blood/plasma donors in rural China. AIDS 2006;20(4):585-591.
7. Zhang F, Haberer JE, Wang Y, et al.: The Chinese free antiretroviral treatment program: Challenges and responses. AIDS 2007;21(Suppl 8):S143-148.
8. Zhang FJ, Pan J, Yu L, Wen Y, and Zhao Y: Current progress of China's free ART program. Cell Res 2005;15(11-12):877-882.
9. Zhao F, Wang Z, and Li WJ: Human immunodeficiency virus type 1 subtypes prevalence in central China. Yonsei Med J 2009;50(5):644-649.
10. Li Z, He X, Wang Z, et al.: Tracing the origin and history of HIV-1 subtype B' epidemic by near full-length genome analyses. AIDS 2012;26(7):877-884.
11. Liu J, Yue J, Wu S, and Yan Y: Polymorphisms and drug resistance analysis of HIV-1 CRF01-AE strains circulating in Fujian Province, China. Arch Virol 2007;152(10):1799-1805.
12. Li Y, Uenishi R, Hase S, et al.: Explosive HIV-1 subtype B' epidemics in Asia driven by geographic and risk group founder events. Virology 2010;402(2):223-227.
13. Yuan Y, Cao XL, Liu HW, et al.: [Study on the transmission of drug resistant human immunodeficiency virus-1 in Henan province]. Zhonghua Yu Fang Yi Xue Za Zhi 2009;43(11):956-959.
14. Gonzalez LM, Santos AF, Abecasis AB, et al.: Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. J Antimicrob Chemother 2008;61(6):1201-1204.
15. Goodman D, Hluhanich R, Waters J, et al.: Integrase inhibitor resistance involves complex interactions among primary and secondary resistance mutations: A novel mutation L6V/I associated with E92Q and increases resistance. Antivir Ther 2008;13(3):A15.
16. Liao L, Xing H, Shang H, et al.: The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIVinfected individuals in China. J Acquir Immune Defic Syndr 2010;5( Suppl 1):S10-14.
17. Ye JR, Lu HY, Wang WS, et al.: The prevalence of drug resistance mutations among treatment-naive HIV-infected individuals in Beijing, China. AIDS Res Hum Retroviruses 2012;28(4):418-423.
18. Xue XJ, Xing H, Cui WG, et al.: [Prevalence of HIV-1 drug resistance from those newly confirmed cases in Henan province, 2010-2011]. Zhonghua Liu Xing Bing Xue Za Zhi 2012;33(9):989-990.